QBiotics lodges Prospectus in preparation for share offer to Existing Shareholders

17 May 2021

QBiotics Group Limited (QBiotics) is pleased to announce that it has today lodged a Prospectus with the Australian corporate regulator, the Australian Securities and Investments Commission (ASIC). QBiotics is undertaking an offer to raise a minimum of $5,000,000, maximum of $10,000,000 with a provision of oversubscriptions of up to $2.5 million, from Existing Shareholders (being, holders of shares in QBiotics as at 5pm on 17 May 2021) (Offer). Full details of the Offer are set out in the Prospectus. The Prospectus is available to be viewed at qbiotics.com/prospectus.

The Prospectus is subject to an exposure period of seven days from the date of lodgement of the Prospectus with ASIC, or such other period (not exceeding 14 days) as ASIC may require. QBiotics will not be accepting applications during the Exposure Period. Application forms for the Offer will not accompany the Prospectus or be available during the Exposure Period. Existing Shareholders will be notified after the expiry of the Exposure Period following which the Prospectus together with the Application Form will be made available via QBiotics website at qbiotics.com/prospectus.

For the protection of all shareholders and investors, the Company has halted the off market transfers of shares during this Prospectus review period.